A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus
NCT00002287 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To evaluate the safety and effectiveness of Retrovir (AZT) when used as prophylaxis for health care workers at risk for HIV infection from exposure to HIV-contaminated blood or blood components.
Conditions
- HIV Infections
Interventions
- DRUG
-
Zidovudine
Sponsors & Collaborators
-
Glaxo Wellcome
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials
NCT02187107 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients
NCT00002326 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants
NCT05184452 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
NCT00002307 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection
NCT00414518 ·Status: COMPLETED ·Phase: NA
-
A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients
NCT00002195 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV
NCT00000791 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)
NCT00002079 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002369 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
NCT00005017 ·Status: UNKNOWN ·Phase: PHASE4
-
A Comparison of 141W94 and Indinavir in HIV-Infected Patients
NCT00002202 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Viracept in HIV-Positive Women
NCT00002171 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.
NCT00081588 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV
NCT00082394 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Islatravir (MK-8591) in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003)
NCT02217904 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection
NCT00002347 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Zidovudine Plus Acyclovir in HIV-Infected Patients
NCT00001010 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs
NCT00002217 ·Status: COMPLETED ·Phase: NA
-
Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients
NCT01540240 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs
NCT00001067 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Bictegravir (GS-9883) in Human Immunodeficiency Virus (HIV)-1 Infected Participants
NCT02275065 ·Status: COMPLETED ·Phase: PHASE1
-
Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV
NCT00001119 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV
NCT00441298 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen
NCT00002238 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs
NCT00002206 ·Status: COMPLETED ·Phase: PHASE1